iTechDachs:
Und ein kurzer Artikel dazu
19.11.18 14:48
Marlborough startup drugmaker RXI Pharmaceuticals now has a runway extending into 2020 as the company continues to reinvent itself and rebrand into a pharmaceutical firm focused on fighting cancer.
Xtrackers MSCI Korea UCITS ETF 1C
Perf. 12M: +234,20%
Xtrackers MSCI Taiwan UCITS ETF 1D
Perf. 12M: +117,11%
Xtrackers MSCI Taiwan UCITS ETF 1C
Perf. 12M: +116,01%
Xtrackers Nikkei 225 UCITS ETF 2D - EUR Hedged
Perf. 12M: +90,69%
Xtrackers CSI500 Swap UCITS ETF 1C
Perf. 12M: +82,72%